Welcome to our dedicated page for Azenta news (Ticker: AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.
Azenta, Inc. provides life sciences solutions focused on cold-chain sample management, automated storage, consumables, informatics, repository services and multiomics offerings. Its updates commonly cover the Sample Management Solutions and Multiomics businesses, including genomic services, gene synthesis execution, sample storage, high-throughput processing and branded products such as GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro and Barkey.
Azenta news also includes quarterly operating results, guidance updates, long-range planning, governance and leadership changes, customer and research partnerships, and acquisition activity. The completed acquisition of UK Biocentre expanded the company’s sample management, sample storage and processing capabilities in the United Kingdom and added a European operational hub for its Sample Repository Services business.
Azenta, Inc. (Nasdaq: AZTA) appointed Matthew McManus as Chief Operating Officer, effective January 17, 2022. Dr. McManus, with over 25 years in the life sciences sector, will oversee Life Sciences Products, Services, and commercial operations, reporting directly to the CEO. He previously held senior roles at Bio-Techne and Asuragen. The company has transitioned its name and ticker from Brooks Automation, Inc. to Azenta as of December 1.
Azenta specializes in life sciences solutions, including cold-chain sample management and genomic services.
Azenta, Inc. (Nasdaq: AZTA) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 3:45 p.m. EST. The conference will be held virtually, and the presentation can be accessed through the Azenta investor relations website. A replay will be available post-event. Recently rebranded from Brooks Automation, Azenta provides life sciences solutions and cold-chain sample management services globally. The company is headquartered in Chelmsford, MA, and operates in North America, Europe, and Asia.
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 24th Annual Needham Virtual Growth Conference on January 10, 2022, with a webcast starting at 1:15 p.m. EST. The event will be accessible via the Azenta investor relations website, with a replay available afterward.
Previously known as Brooks Automation, Inc., Azenta focuses on life sciences, offering cold-chain sample management and genomic services. The company also reports the Semiconductor Solutions Group as discontinued operations due to a pending sale.